Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer.

CONCLUSION: In this small cohort of patients, we conclude that this combination is quite feasible and resulted in prolonged stability in some patients. Further development of this regimen is warranted.
PMID: 32097933 [PubMed - as supplied by publisher]

Source: Oncology - February 24, 2020 Category: Cancer & Oncology Authors: Rogers JE, Xiao L, Trail A, Blum Murphy M, Palmer M, Ajani JA Tags: Oncology Source Type: research